Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.37 USD | +1.70% | +3.33% | -16.80% |
26/04 | Cytokinetics Appoints Sung Lee as CFO | MT |
18/04 | Vir Biotechnology, Inc. Announces Stepping Down of Sung Lee as Chief Financial Officer, Effective May 3, 2024 | CI |
Business Summary
Number of employees: 587
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody-based Therapies
100.0
%
| 1,616 | 100.0 % | 86 | 100.0 % | -94.67% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 1,616 | 100.0 % | 86 | 100.0 % | -94.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Sung Lee
DFI | Director of Finance/CFO | 53 | 27/23/27 |
Jennifer Towne
CTO | Chief Tech/Sci/R&D Officer | - | 06/11 |
Aine M. Hanly
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/21/01 |
George Scangos
BRD | Director/Board Member | 76 | 01/17/01 |
Richard Lepke
IRC | Investor Relations Contact | - | 01/01 |
Sasha Ellis
PRN | Corporate Officer/Principal | - | 10/23/10 |
Lynne Krummen
PRN | Corporate Officer/Principal | - | 01/18/01 |
Corporate Officer/Principal | 73 | - | |
Jeff Calcagno
PRN | Corporate Officer/Principal | - | 15/23/15 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Sigal
BRD | Director/Board Member | 72 | 02/20/02 |
Robert Perez
BRD | Director/Board Member | 59 | 01/17/01 |
Robert More
BRD | Director/Board Member | 56 | 01/16/01 |
Phillip Sharp
BRD | Director/Board Member | 79 | 01/17/01 |
Robert Nelsen
FOU | Founder | 60 | 07/16/07 |
Vicki Sato
CHM | Chairman | 75 | 01/16/01 |
George Scangos
BRD | Director/Board Member | 76 | 01/17/01 |
Director/Board Member | 48 | 01/19/01 | |
Janet Napolitano
BRD | Director/Board Member | 65 | 28/20/28 |
Chief Executive Officer | 56 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 135,843,977 | 116,627,968 ( 85.85 %) | 0 | 85.85 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.80% | 1.14B | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- VIR Stock
- Company Vir Biotechnology, Inc.